Expert Practice Evaluation Form


To assist us in evaluating the effectiveness of this activity and to make recommendations for future prIME Oncology educational offerings, please complete this evaluation form.

Thank you in advance for your constructive feedback.


Alastair Ritchie, MD View Webcast
Renal cell carcinoma: The emerging role of adjuvant and neoadjuvant therapy

Alastair W. S. Ritchie, MD
Medical Research Council
London, United Kingdom

Camillo Porta, MD View Webcast
Intermediate-risk renal cell carcinoma: Best choice and sequencing of therapy

Camillo Porta, MD
IRCCS San Matteo University Hospital
Pavia, Italy

Kurt Miller, MD View Webcast
PSA-only relapse following local therapy for high-risk prostate cancer

Kurt Miller, MD
Benjamin Franklin Medical Center
Berlin, Germany

Peter Mulders, MD, PhD View Webcast
Hormone-responsive prostate cancer with bone metastases: How should therapy be sequenced?

Peter Mulders, MD, PhD
University Medical Center Nijmegen
Nijmegen, The Netherlands

Camillo Porta, MD View Webcast
Castration-resistant prostate cancer: Optimal management of a patient with good performance status

Camillo Porta, MD
IRCCS San Matteo University Hospital
Pavia, Italy

Support for this activity has been provided by Novartis Oncology and GlaxoSmithKline.